In this context, professor Alexandru Rafila, the most reputable Romanian epidemiologist and the Romanian representative at the European Union of Medical Specialists, issued a warning: don’t buy this medicine over the internet, as it is counterfeit!

Alexandru Rafila was interviewed by one Romanian TV channel about this medicine. He told the journalists that Remdesivir is an injectable medicine and it is used only in hospitals. This is why his advice was not to buy this medicine over the internet and also not to buy it to take it as a prophylactic measure: “It is a medicine to be injected only to patients in critical condition!“. He added that Remdesivir is available outside US only to countries such as Romania, which conducts clinical trials for Gilead Sciences, Inc.

Also, he expressed his reservations regarding the efficiency of Remdesivir until clinical trials show its real potential in curing COVID-19 patients: “At present, we should talk about an economic, but also a political context. When a different study appeared in China, showing Remdesivir has no effect, the American stock exchange and mostly the value of the Gilead Sciences (the developer of the medicine) collapsed. When the American authorities decided to offer a licence to Gillead Sciences to produce this medicine, the stocks get their values back.”

Photo explanation: Gillead Sciences specialists conducting Remdesivir tests

The post Romanian Reputable Epidemiologist: Don’t Buy Remdesivir over the Internet! appeared first on Valahia.News.

The antiviral drug Remdesivir belongs to the biotechnology company Gilead Sciences and may become the standard treatment for COVID-19, at least in the United States. The clinical study, conducted with the support of the National Institute of Allergy and Infectious Diseases (NIAID) in the US, shows that Remdesivir has a clear-cut, significant positive effect in diminishing the time to recover for patients infected with Coronavirus. Thus, preliminary results show that patients who received Remdesivir had a 31% faster recovery period than patients who received a placebo. Moreover, the mortality rate was 8.0% in the group that received Remdesivir, compared to 11.6% for the placebo group.

Dr. Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases (NIAID), says the findings are “significant”, anticipating that “this will be the standard for treatment“.

On top of that, Donald Trump has launched an acceleration program called “Operation Warp Speed” to develop a Coronavirus vaccine. The main purpose of this program is to reduce the period of development of a vaccine by eight months and it’s based on a collaboration between private pharmaceutical companies and civilian and military governmental agencies.

The program will start with rapid animal testing of the world’s most promising experimental vaccines, from almost 100 trial vaccines developed so far, followed by human clinical trials.

Photo source: Coronavirus.gov

The post The Americans Presented Remdesivir as the Antiviral Drug against COVID-19, Now Looking for Vaccine appeared first on Valahia.News.